Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MDA Adverse Incident Reports Up 11%, But Firms Pleased With Review Times

This article was originally published in The Gray Sheet

Executive Summary

The rising number of medical device reports in the UK has prompted a strategic review within the country's Medical Devices Agency, according to MDA's 2002 adverse incidents report released March 27

You may also be interested in...



International News In Brief

A European CDC?: EU Center for Disease Prevention & Control would be created under a proposal adopted by the European Commission July 23. Developed in response to the SARS outbreak, the initiative would enhance microbiological labs' quality assurance schemes. Pending passage through Parliament and Council, the agency could be in operation by 2005...

International News In Brief

A European CDC?: EU Center for Disease Prevention & Control would be created under a proposal adopted by the European Commission July 23. Developed in response to the SARS outbreak, the initiative would enhance microbiological labs' quality assurance schemes. Pending passage through Parliament and Council, the agency could be in operation by 2005...

MHRA Will Pay Equal Attention To Devices and Drugs, UK Health Chief Vows

Consolidaton of the Medical Devices Agency and the Medicines Control Agency will retain MDA's focus on the device industry, UK Health Minister Lord Philip Hunt said Sept. 19

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018126

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel